Venrock PIPEs Durect

Venrock has agreed to buy approximately $10 million worth of common shares in drug company Durect Corp. (Nasdaq: DRRX), at $2.25 per share.

11 September 2009•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail